Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis.
Daitoku S, Takenaka K, Yamauchi T, Yurino A, Jinnouchi F, Nunomura T, Eto T, Kamimura T, Higuchi M, Harada N, Saito N, Miyamoto T, Iwasaki H, Akashi K.
Daitoku S, et al. Among authors: iwasaki h.
Exp Hematol. 2016 Sep;44(9):817-825.e3. doi: 10.1016/j.exphem.2016.05.001. Epub 2016 May 13.
Exp Hematol. 2016.
PMID: 27185380
Free article.